HOUSE_OVERSIGHT_024773.jpg

1.28 MB

Extraction Summary

0
People
4
Organizations
1
Locations
1
Events
3
Relationships
3
Quotes

Document Information

Type: Financial report page / disclaimer
File Size: 1.28 MB
Summary

This document serves as the introduction to Chapter VIII of an Ackrell Capital report, presenting their 2018 list of the top 100 private cannabis companies. The text outlines the subjective selection criteria, highlights the financial risks and challenges faced by early-stage cannabis companies, and includes a disclaimer regarding potential conflicts of interest due to Ackrell Capital's investment activities.

Organizations (4)

Timeline (1 events)

Top 100 Private Cannabis Companies 2018

Locations (1)

Location Context

Relationships (3)

Key Quotes (3)

"In this chapter, we present our current list of the Top 100 Private Cannabis Companies."
Source
HOUSE_OVERSIGHT_024773.jpg
Quote #1
"Most companies on our list are in early stages of development, and many will need to raise capital to succeed."
Source
HOUSE_OVERSIGHT_024773.jpg
Quote #2
"Readers should be aware that we may have a conflict of interest that could affect the objectivity of our decision to include a company in the list."
Source
HOUSE_OVERSIGHT_024773.jpg
Quote #3

Full Extracted Text

Complete text extracted from the document (1,776 characters)

ACKRELL
CAPITAL
CHAPTER VIII
Top 100
Private Cannabis Companies 2018
In this chapter, we present our current list of the Top 100 Private Cannabis Companies. Our determination to include companies on the list is subjective, and the list is intended to be a cross-section of the types of companies in the cannabis industry. Our list comprises privately held companies, primarily U.S. companies, companies we believe have a strong reputation or position in their market segments and companies pursuing a line of business we consider promising. We intend to update our list periodically, and we expect it may change significantly over time.
Most companies on our list are in early stages of development, and many will need to raise capital to succeed. Raising capital for early-stage companies in any industry is extremely challenging. Early-stage cannabis companies seeking capital face the same challenges as early-stage companies in other industries but must also address challenges unique to the cannabis industry. Although we hope the companies on our list ultimately succeed, we expect some will go out of business for any number of reasons, including lack of access to capital.
Inclusion in our list does not represent an investment recommendation or endorsement of any particular company or product. We have made investments in and conducted investment banking and other services for companies included in the Top 100 Private Cannabis Companies 2018 list, and may do so in the future. Readers should be aware that we may have a conflict of interest that could affect the objectivity of our decision to include a company in the list. For additional disclosures and disclaimers, see page 175.
© 2017Ackrell Capital, LLC | Member FINRA / SIPC
137
HOUSE_OVERSIGHT_024773

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document